Every 8-K that The OLB Group, Inc. (OLB) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow OLB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OLB filings page.
The OLB Group, Inc. entered into an Equity Distribution Agreement with Maxim Group LLC to establish an at-the-market equity offering program for its common stock. Under this arrangement, Maxim will act as sales agent or principal to sell shares on Nasdaq or through other permitted at-the-market methods as directed by the company.
The company controls the sale parameters and is not obligated to sell any shares. A prospectus supplement filed August 7, 2026 registers up to $1,600,000 of common shares under an existing Form S-3 shelf registration. Maxim will receive a 3.0% commission on gross sales and reimbursement of certain expenses. The program continues until terminated under the agreement’s notice provisions.
The OLB Group, Inc. entered into a private placement with an institutional investor, raising approximately $3.0 million through pre-funded warrants for up to 2,857,142 shares of common stock and warrants for up to 3,571,428 shares at a combined purchase price of $1.05 per unit.
The new warrants have an exercise price of $0.92 per share and a five-year term starting on the resale registration statement’s effectiveness. OLB agreed to cut the exercise price of certain 2021 warrants to $0.92 and extend their term to February 19, 2029, granted the investor registration rights for resale of underlying shares, and accepted short-term restrictions on issuing additional equity or variable-rate financings. D. Boral Capital LLC earned a 6% cash fee on gross proceeds plus $50,000 in expenses.
The OLB Group, Inc. filed a Form 8-K to share that it issued a press release providing an update on the planned spin-off of its subsidiary DMint, Inc. The press release is included with the filing as Exhibit 99.1 under Regulation FD disclosure.
The company also includes standard forward-looking statement language, noting that expectations about future events involve risks and uncertainties. It directs readers to the risk factors and other sections of its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
The OLB Group, Inc. received a notice from Nasdaq on January 29, 2026 stating that its common stock had closed below the required $1.00 minimum bid price for 30 consecutive business days, triggering a non-compliance status with Nasdaq Listing Rule 5550(a)(2).
The company has 180 calendar days, until July 28, 2026, to regain compliance. If the closing bid price is at least $1.00 for 10 consecutive business days within this grace period, compliance will be restored. If compliance is not regained, Nasdaq may initiate delisting, although OLB would have the right to appeal. The stock will continue trading on the Nasdaq Capital Market during the grace period, subject to meeting other listing requirements.
The OLB Group, Inc. entered into a financing deal with institutional investors, raising approximately $1.3 million in gross proceeds through a registered direct stock sale paired with a concurrent private warrant placement. The company sold 2,166,666 shares of common stock and issued Warrants to purchase up to 2,166,666 additional shares, at a combined price of $0.60 per share and Warrant, with the Warrants exercisable six months after issuance at $0.78 per share for five years. The company plans to use the net proceeds for general and working capital purposes and agreed for 15 days after closing not to issue or agree to issue additional equity, subject to exceptions. D. Boral Capital LLC acted as exclusive placement agent, earning a 6% cash fee on gross proceeds, reimbursement of $50,000 in expenses, and short-term rights of first refusal on future advisory and financing roles.